Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH903 plus FOLFIRI in unresectable recurrent or metastatic colorectal cancer
CTR20181721Phase 2Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Sep 2018
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in colorectal cancer (CRC), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Sep 2018; status: completed.
02
Drugs
conbercept
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20181721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181721.